The political reporters at President-elect Donald Trump’s news conference on Jan. 11 were so focused on Russia and conflicts of interest that they missed a true nugget of news. Early into his press conference, Donald Trump said something that sent drug stocks into a tailspin, and made pharmaceutical executives cringe. He first complained that too Read More
The new House rules changes may seem harmless, but they make the House less transparent and can be used to intimidate citizens and federal workers.
Advocates who want Congress to do more to protect public health and safety, the environment, and our financial system, are gearing up for a tough four years. But new polling offers them some hope for the battles ahead.
Using a dubious strategy, a major law firm is trying to hamstring Greenpeace and other environmental groups on behalf of a paper manufacturer. If the ploy succeeds, it would have a chilling effect on free speech.
Europeans worry that increased hate speech and harassment after Trump’s victory will destabilize US security.
European election observers criticized that millions of voters are excluded from the process and that local laws help suppress the vote. The election itself, however, was run cleanly with just some glitches.
Just a few weeks ago, the two massive trade deals President Barack Obama wants to complete before leaving office looked to be in trouble. But in politics, never count out anything on the wish list of multinational corporations.
Former Senator Bob Graham has spent 15 years searching for the real story behind 9/11. Both the Bush and Obama administrations have done everything to block him.
The US offers safe havens to criminals using secret shell companies. Recent scandals are pushing Congress to act, but reforms are opposed by lawyers and by the states that profit from selling secrecy.
While trade negotiators insist TTIP talks will continue as planned, critics of the deal are pushing for a change in direction.
TTIP’s fate remains unclear, but the EU continues to press for changes that could harm local governments and drug safety in the US.